Synaptic Dysfunction
research programme
Alzheimer Disease
clinical expertise
research findings
clinical utilisation
training programme
trained ESRs
novel therapies
excellent opportunities
big pharmaceutical companies
novel pharmaceutical targets
SyDAD partners
large number of failed clinical trials
excellent intersectoral
requirements of academia
economic burden of AD patients
complementary expertise
collaborative approach
future implementation
interdisciplinary career opportunities
mind-set of future commercial
new generation of researchers
early-stage researchers
innovation
D programmes
main connection point
transferable skills
cognitive decline
cutting-edge methodology
retraction
nervous system R
overwhelming increase of dementia costs
aging population
pathology
experience
suffering
urgent need
different pathways
drug discovery platform
key components
private sector
century
understanding
cross
clinics
project
major societal challenges
Increased collaboration
solid ground
network
society
environment